Technologies Available for Licensing
VACCINE FOR TRANSCUTANEOUS IMMUNIZATION
A vaccine delivered by transcutaneous immunization provides an effective treatment against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby. For example, one, two, three, four, five or more antigens derived from ETEC and capable of inducing an antigen-specific immune response (e.g., toxins, colonization or virulence factors) and one or more optional adjuvant (e.g., whole bacterial ADP-ribosylating exotoxins, B subunits or toxoids thereof, detoxified mutants and derivatives thereof) are used to manufacture vaccines or to induce systemic and/or mucosal immunity.
Number:7,527,802
Date:2009-05-05
Type: Issued
Category: Vaccine
More Detail:Visit USPTO.GOV
Lab:WRAIR
Inventor(s):GLENN, G.; CASSELS, F.